Factors Linked to Development of Pediatric Psoriasis Identified
Factors independently linked to development include atopic dermatitis, family history of psoriasis, skin and fungal infections
Psoriasis
Tapinarof Cream Under Review for Plaque Psoriasis
Tapinarof is an investigational, novel, aryl hydrocarbon receptor modulating agent designed as a once-daily, steroid-free topical cream.
Skyrizi Now Available as a Single-Dose Injection for Plaque Psoriasis
In April 2021, the FDA approved the sBLA for the single-dose Skyrizi 150mg injection based on data from 3 clinical trials.
Papers on COVID-19 in Psoriasis, Psoriatic Arthritis Carry Risk for Bias
Risk for bias high in papers relating to patients with psoriasis and psoriatic arthritis receiving biologic therapies
MPR Weekly Dose Podcast Episode 87
This week we have news of the FDA requesting a change to statin prescribing labels, a new vaccine for streptococcus pneumoniae, a new plaque psoriasis cream, a stem cell therapy gets fast tracked as a possible Parkinson disease treatment, and there’s a new treatment approved for Progressive Familial Intrahepatic Cholestasis.
Wynzora Cream Now Available for Plaque Psoriasis
Wynzora is a combination of calcipotriene, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid.
Cosentyx Approved for Pediatric Plaque Psoriasis
The approval was based on data from two phase 3 trials that evaluated the use of Cosentyx in patients 6 to 18 years of age with severe plaque psoriasis who were candidates for systemic therapy.
Clinical Challenge: Drop-Like Lesions on Back and Chest
A 29-year-old man presents for evaluation of a rash on his body that began 2 weeks ago. Can you make the correct diagnosis?
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
Apremilast Under Review for Mild to Moderate Plaque Psoriasis
The sNDA is supported by data from the multicenter, double-blind, placebo-controlled phase 3 ADVANCE trial.
